EDIT

Editas Medicine Inc

Jun 16 • 04:00PM ET

2.36

-0.10 -4.07 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NTLA CRSP PRME DTIL RGNX ABEO SLN VYGR MGTX SLDB

| Held by: VTI IWM VXF IWN IBB VTWO VHT SCHA IWC VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.22	Insider Own	7.50%	Shs Outstand	153.46M	Perf Week	-10.94%
Market Cap	362.17M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-0.20%	Shs Float	141.95M	Perf Month	-9.92%
Enterprise Value	310.49M	PEG	-	EPS next Q	-0.27	Inst Own	46.11%	Short Float	10.61%	Perf Quarter	-4.07%
Income	-108.95M	P/S	9.36	EPS this Y	44.05%	Inst Trans	0.74%	Short Ratio	7.46	Perf Half Y	-6.72%
Sales	38.69M	P/B	52.40	EPS next Y	4.03%	ROA	-52.76%	Short Interest	15.07M	Perf YTD	15.12%
Book/sh	0.05	P/C	2.93	EPS next 5Y	16.43%	ROE	-326.07%	52W High	4.54 -47.99%	Perf Year	9.26%
Cash/sh	0.81	P/FCF	-	EPS past 3/5Y	17.49% 1.84%	ROIC	-175.22%	52W Low	1.66 42.17%	Perf 3Y	-73.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.15% -14.89%	Gross Margin	90.07%	Volatility	7.15% 10.72%	Perf 5Y	-93.26%
Dividend TTM	-	EV/Sales	8.03	EPS Y/Y TTM	59.82%	Oper. Margin	-230.09%	ATR (14)	0.26	Perf 10Y	-92.46%
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	7.97%	Profit Margin	-281.59%	RSI (14)	37.75	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	72.14%	SMA20	-16.02%	Beta	2.13	Target Price	5.66
Payout	-	Debt/Eq	16.32	Sales Q/Q	-39.22%	SMA50	-20.04%	Rel Volume	1.11	Prev Close	2.46
Employees	87	LT Debt/Eq	13.10	Earnings	May 05 BMO	SMA200	-11.38%	Avg Volume	2.02M	Price	2.36
IPO	Feb 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.14% -55.58%	Trades		Volume	2,245,942	Change	-4.07%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)